BioCentury
ARTICLE | Clinical News

ADAMTS13 regulatory update

October 20, 2008 7:00 AM UTC

EMEA's Committee for Orphan Medicinal Products (COMP) issued a positive opinion to grant Orphan Drug designation for ADAMTS13 to treat thrombotic thrombocytopenic purpura ( TTP). Baxter licensed ex-Ja...